Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 09:35 am Sale | 2021-12-31 | 13G | Puma Biotechnology, Inc. PBYI | Camber Capital Management LP | 2,050,000 5.010% | -505,000 (-19.77%) | Filing History |
| 2022-02-11 4:21 pm Sale | 2021-12-31 | 13G | Puma Biotechnology, Inc. PBYI | James E. Flynn | 0 0.000% | -3,959,741 (Position Closed) | Filing History |
| 2022-02-10 08:32 am Purchase | 2021-12-31 | 13G | Puma Biotechnology, Inc. PBYI | The Vanguard Group | 3,680,187 9.000% | 283,498 (+8.35%) | Filing History |
| 2022-02-10 06:31 am Sale | 2021-12-31 | 13G | Puma Biotechnology, Inc. PBYI | STATE STREET CORP STT | 578,090 1.410% | -1,663,947 (-74.22%) | Filing History |
| 2022-02-08 4:43 pm Purchase | 2021-12-31 | 13G | Puma Biotechnology, Inc. PBYI | GOLDMAN SACHS GROUP INC GS | 2,097,647 5.100% | 2,097,647 (New Position) | Filing History |
| 2022-02-02 7:11 pm Purchase | 2021-12-31 | 13G | Puma Biotechnology, Inc. PBYI | BlackRock Inc. BLK | 3,204,237 7.800% | 208,222 (+6.95%) | Filing History |
| 2022-01-14 4:08 pm Purchase | 2022-01-06 | 13G | Puma Biotechnology, Inc. PBYI | Integrated Core Strategies (US) LLC | 2,237,699 5.500% | 2,237,699 (New Position) | Filing History |
| 2021-11-19 4:10 pm Purchase | 2021-11-10 | 13G | Puma Biotechnology, Inc. PBYI | Integrated Core Strategies (US) LLC | 2,004,338 4.900% | 1,215,638 (+154.13%) | Filing History |
| 2021-11-10 4:08 pm Sale | 2021-10-31 | 13G | Puma Biotechnology, Inc. PBYI | Alger Associates, Inc. | 890,396 2.180% | -2,525,607 (-73.93%) | Filing History |
| 2021-02-16 4:51 pm Purchase | 2020-12-31 | 13G | Puma Biotechnology, Inc. PBYI | Alger Associates, Inc. | 3,416,003 8.590% | 3,416,003 (New Position) | Filing History |
| 2021-02-16 08:21 am Purchase | 2020-12-31 | 13G | Puma Biotechnology, Inc. PBYI | Camber Capital Management LP | 2,555,000 6.430% | 155,000 (+6.46%) | Filing History |
| 2021-02-12 3:58 pm Sale | 2021-12-31 | 13G | Puma Biotechnology, Inc. PBYI | EcoR1 Capital, LLC | 0 0.000% | -2,536,156 (Position Closed) | Filing History |
| 2021-02-12 12:30 pm Purchase | 2020-12-31 | 13G | Puma Biotechnology, Inc. PBYI | James E. Flynn | 3,959,741 9.960% | 1,681,588 (+73.81%) | Filing History |
| 2021-02-10 3:13 pm Sale | 2020-12-31 | 13G | Puma Biotechnology, Inc. PBYI | STATE STREET CORP STT | 2,242,037 5.640% | -1,265,115 (-36.07%) | Filing History |
| 2021-02-10 11:40 am Sale | 2020-12-31 | 13G | Puma Biotechnology, Inc. PBYI | The Vanguard Group | 3,396,689 8.540% | -589,437 (-14.79%) | Filing History |
| 2021-02-09 4:37 pm Sale | 2020-12-31 | 13G | Puma Biotechnology, Inc. PBYI | Integrated Core Strategies (US) LLC | 788,700 2.000% | -1,161,606 (-59.56%) | Filing History |
| 2021-01-29 5:23 pm Purchase | 2020-12-31 | 13G | Puma Biotechnology, Inc. PBYI | BlackRock Inc. BLK | 2,996,015 7.500% | 104,679 (+3.62%) | Filing History |
| 2020-08-10 2:52 pm Purchase | 2020-08-07 | 13G | Puma Biotechnology, Inc. PBYI | James E. Flynn | 2,278,153 5.740% | 2,278,153 (New Position) | Filing History |
| 2020-06-29 6:03 pm Purchase | 2020-06-18 | 13G | Puma Biotechnology, Inc. PBYI | Camber Capital Management LP | 2,400,000 6.100% | 2,400,000 (New Position) | Filing History |